COLUMBIA WANGER ASSET MANAGEMENT LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 161 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2015. The put-call ratio across all filers is 1.63 and the average weighting 0.2%.

Quarter-by-quarter ownership
COLUMBIA WANGER ASSET MANAGEMENT LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q4 2017$67,000,000
-21.2%
1,444,584
-9.5%
1.00%
-20.4%
Q3 2017$85,021,000
+0.3%
1,596,334
+17.0%
1.26%
+4.0%
Q2 2017$84,745,000
+1.0%
1,364,434
+10.2%
1.21%
+2.6%
Q1 2017$83,900,000
+1.5%
1,237,825
+5.3%
1.18%
+1.6%
Q4 2016$82,658,000
-7.3%
1,175,616
-6.5%
1.16%
-0.8%
Q3 2016$89,191,000
+111.2%
1,257,271
+45.6%
1.17%
+138.6%
Q2 2016$42,229,000
-30.6%
863,392
-10.2%
0.49%
-25.2%
Q1 2016$60,850,000
-51.2%
961,145
-13.5%
0.66%
-47.6%
Q4 2015$124,695,000
+3.4%
1,111,566
-11.3%
1.25%
+29.8%
Q3 2015$120,639,000
-49.5%
1,252,614
-46.3%
0.96%
-37.4%
Q2 2015$238,996,000
+71.5%
2,334,173
+4.0%
1.54%
+102.8%
Q1 2015$139,374,000
+138.7%
2,244,710
+68.7%
0.76%
+162.3%
Q4 2014$58,386,000
-42.4%
1,330,567
-25.7%
0.29%
-38.1%
Q3 2014$101,375,000
+31.0%
1,791,082
-0.1%
0.47%
+50.2%
Q2 2014$77,393,000
-5.5%
1,793,182
-0.1%
0.31%
-3.4%
Q1 2014$81,868,0001,795,4820.32%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2015
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders